INGN

5.3002.21%
KP

Kevin P. Smith

General Counsel, Secretary & Executive VP of Business Development

Mr. Kevin P. Smith is Secretary, General Counsel and Executive Vice President, Business Development at Inogen, Inc. from July 22, 2024. He was General Counsel of Sirtex Medical Ltd. since 2018 and was its Executive Vice President of Business Development from October 2018 to June 2024. Mr. Smith serves as a Director at Nanospectra Biosciences, Inc., since September 2020. Mr. Smith served as Chief Compliance Officer of Sirtex Medical Pty. Ltd. (formerly known as Sirtex Medical Limited) since 2018 until October 2019. Mr. Smith served as General Counsel and Vice President of AB Sciex LLC. Mr. Smith managed the legal, intellectual property, trade compliance and EHS functions for the AB Sciex LLC. In his prior roles, Mr. Smith served as Vice President and Associate General Counsel at Flexion Therapeutics from 2017 to 2018, as General Counsel for the Danaher Life Sciences Platform from 2012 to 2017 and in several senior legal leadership positions within Novartis Pharmaceuticals in Switzerland and Massachusetts from 2005 to 2012. Mr. Smith joined AB SCIEX from Novartis, where he was General Counsel for the Novartis Molecular Diagnostics Unit. Mr. Smith held a number of legal leadership positions at Novartis Pharma, including Head of Legal for General Medicines (NSO, IID and Established Medicines) and for the Emerging Growth Markets. Before Novartis, Mr. Smith worked for international law firms in New York, Silicon Valley and London. He is admitted to practice law in New York and California and is an admitted US patent attorney. He holds a B.S. in Mechanical Engineering from Rensselaer Polytechnic Institute and a Juris Doctorate from Albany Law School.

Positions